College of Pharmacy
Contact Us
3900 University Blvd.
Tyler, Tx 75799
Office Hours:
M-F 8 a.m. - 5 p.m.
800 UT TYLER
Ph: 903.565.5777
pharmacy@uttyler.edu
Pharmaceutical Sciences and Health Outcomes - Pharmacy
Osama A. Shoair, PhD
Title: Assistant Professor
Department: Pharmaceutical Sciences and Health Outcomes - Pharmacy
Building: WTB 346
Email: oshoair@uttyler.edu
Phone: 903.565.6523
Degrees
-
PhD, Pharmacotherapy and Outcomes Science, 2013
Virginia Commonwealth University, Richmond, VA -
Certificate, Aging Studies, 2013
Virginia Commonwealth University, Richmond, VA -
BS, Pharmacy, 2006
Misr International University, Cairo, Egypt
Postdoctoral Training
-
Postdoctoral Research Fellow
Oct 2014 – Jan 2016
Program for Pharmaceutical Economics and Policy Studies, University of California, San Francisco -
Postdoctoral Research Fellow
Jul 2013 – May 2014
Pharmacotherapy Outcomes Research Center, The University of Utah
Biography
Dr. Osama Shoair is an Assistant Professor in the Department of Pharmaceutical Sciences and Health Outcomes at Fisch College of Pharmacy at The University of Texas at Tyler. Dr. Shoair received his Bachelor of Science in Pharmaceutical Sciences from Misr International University and his Doctor of Philosophy in Pharmacotherapy and Outcomes Science from Virginia Commonwealth University.
Dr. Shoair has completed two postdoctoral research fellowships in patient outcomes and health economics at the University of Utah and University of California, San Francisco.
Dr. Shoair teaching interests include biostatistics, clinical research design, pharmacoepidemiology, and pharmacoeconomics. Dr. Shoair’s research interests are in the area of health economics and outcomes research.
Dr. Shoair serves as a peer reviewer for several journals in the fields of pharmacy education, pharmacotherapy, geriatrics/gerontology, and pharmacoepidemiology. He is also an active member in several professional associations and societies including the American Association of Colleges of Pharmacy (AACP) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and he is a member of the Honor Society of Phi Kappa Phi.